The American Cancer Society's chief scientific officer outlines the group's research agenda, including a new project in ...

U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...

FDA proposes draft guidelines on AI use in drug development, addressing challenges and opportunities for improving safety and ...

Andy Weir's Project Hail Mary (2021), like many works of apocalyptic fiction, is set in a world facing an existential threat.

In December 2024, the Company announced a strategic restructuring of its business operations, including the potential divestiture of its DNA Tagging and Security Products and Services ("DNA Tagging") ...

Alpha-synuclein inhibitors are a class of investigational therapies targeting the pathological aggregation of alpha-synuclein, a protein implicated i ...

According to Statifacts, the global clinical trials market size is calculated at USD 126.30 billion in 2025 and is expected to reach around USD 186.09 billion by 2034, growing at a CAGR of 4.4% from ...

Advanced Ovarian Cancer Pipeline Insights LAS VEGAS, NV, UNITED STATES, February 12, 2025 /EINPresswire / -- As per DelveInsight's assessme ...

As clinical trial complexity, duration, and cost continue to rise, life sciences companies are turning to data to help them ...

A biotechnology company in Research Triangle Park has taken a major step to develop a new option for patients in need of a ...

Cerebral cavernous malformation (CCM) patients treated with oral drug, REC-994, showed reduction in total cerebral and brainstem lesion volume.

A groundbreaking cannabinoid-based antimicrobial, Silvanex, fights drug-resistant infections with a synergy of silver, CBC and CBG.